People who lost Patient or reducing their exposure is killing the SP at the moment.
No update from management is definitely a killer.
The SP become attractive now but we see no buyer.
What a frustrating share to hold.
For long term, nothing has chance much. We will get the approval and starts distributing the product. Revenue will come. By that time I may ask myself, why don’t I get more share below 20c!
People are selling below 20c and I am not buying??
August tomorrow, it shouldn’t be too long before we see news regarding FDA, CFDA and factory production.
I some how knows we will have a bright second half of the year.
GMV Price at posting:
19.0¢ Sentiment: Buy Disclosure: Held
